TargetMol

GSK2256098

Product Code:
 
TAR-T2281
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2281-1mg1mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2281-2mg2mg£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2281-1mL1 mL * 10 mM (in DMSO)£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2281-5mg5mg£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2281-10mg10mg£182.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2281-25mg25mg£292.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2281-50mg50mg£450.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2281-100mg100mg£629.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2281-500mg500mg£1,251.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
GSK-2256098 is a small molecule FAK kinase inhibitor.
CAS:
1224887-10-8
Formula:
C20H23ClN6O2
Molecular Weight:
414.89
Pathway:
Angiogenesis; Tyrosine Kinase/Adaptors; Cytoskeletal Signaling; Apoptosis
Purity:
0.9952
SMILES:
CONC(=O)c1ccccc1Nc1cc(Nc2cc(C)nn2C(C)C)ncc1Cl
Target:
Apoptosis; FAK

References

1. Zhang J, et al. Cell Cycle. 2014, 13(19):3143-9. 2. Paul Mulholland, et al. Neuro Oncol. 2015, 17(Suppl 5): v11. 3. Soria JC, et al. Ann Oncol. 2016, 27(12):2268-2274. 4. Thanapprapasr D, et al. Mol Cancer Ther. 2015, 14(6):1466-75. 5. Auger KR, et al. Eur J Cancer. 2012, 48:118